Cision PR Newswire

CARsgen Presents First Clinical Data on Its In Vivo CAR-T Product Candidate CT1182

SHANGHAI, Nov. 22, 2026 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announces the clinical data...

XDENT LAB Expands the Largest Removable Denture Factory in Vietnam – Forecasting Strong Growth, Pioneering Dental Lab-to-Lab Services for the U.S. Market

HO CHI MINH CITY, Vietnam, Feb. 13, 2025 /PRNewswire/ -- XDENT LAB, one of the leading providers in the field of Removable Denture manufacturing...

Hyundai Motor Group Celebrates 20 Years of Driving Innovation at the Hyundai California Proving Ground

Milestone reaffirms Hyundai Motor Group's commitment to safety, quality, design, and performance More than 5,000 vehicles have been tested...

Restore Vision Announces First Patient Dosed in Phase I/II Clinical Trial of RV-001 for Gene-Agnostic Retinitis Pigmentosa

The first optogenetic "Chimeric Rhodopsin" gene therapy tested in humans. RV-001 starting dose was generally well tolerated in this...

Aker Horizons ASA: Fourth-quarter results 2024

FORNEBU, Norway, Feb. 13, 2025 /PRNewswire/ -- Aker Horizons ASA (OSE: AKH), a developer of green energy and industry, today announced results for the fourth quarter...

Cloud4C Secures Dual AI Specializations on Microsoft Azure, Strengthening AI Capabilities

SINGAPORE, Feb. 13, 2025 /PRNewswire/ -- Cloud4C, a global leader in AI-driven cloud and cybersecurity services, has achieved two prestigious AI specializations on Microsoft...